Additional information - Financial Statement Schedule I (Tables)
|
12 Months Ended |
Jun. 30, 2026 |
|---|
| Additional information - Financial Statement Schedule I |
|
| Statement of condensed statement of profit or loss |
| | | | | | | | | Year ended 30 June | | | 2026 | | 2025 | | 2024 | | | £’000 | | £’000 | | £’000 | Operating expenses excluding exceptional items | | (6,448) | | (7,816) | | (10,866) | Exceptional items | | 306 | | (55) | | (43,324) | Finance income | | 6,992 | | 6,973 | | 2,509 | Profit/(loss) before income tax | | 850 | | (898) | | (51,681) | Income tax expense | | (2) | | (1) | | — | Profit/(loss) for the year | | 848 | | (899) | | (51,681) |
|
| Statement of condensed balance sheet |
| | | | | | | As of 30 June | | | 2026 | | 2025 | | | £’000 | | £’000 | ASSETS | | | | | Non-current assets | | | | | Investment in subsidiaries | | 319,265 | | 319,265 | | | 319,265 | | 319,265 | Current assets | | | | | Amounts owed by subsidiaries | | 229,470 | | 222,642 | Other receivables | | 91 | | 91 | Cash and cash equivalents | | 83 | | 74 | | | 229,644 | | 222,807 | Total assets | | 548,909 | | 542,072 | | | | | | EQUITY AND LIABILITIES | | | | | Equity | | | | | Share capital | | 56 | | 56 | Share premium | | 307,345 | | 307,345 | Treasury shares | | (21,305) | | (21,305) | Retained earnings | | 196,232 | | 195,141 | | | 482,328 | | 481,237 | Current liabilities | | | | | Amounts owed to subsidiaries | | 64,795 | | 59,416 | Other payables | | 1,786 | | 1,419 | | | 66,581 | | 60,835 | Total equity and liabilities | | 548,909 | | 542,072 |
|
| Statement of condensed statement of changes in equity |
| | | | | | | | | | | | | Share | | Share | | Treasury | | Retained | | | | | capital | | premium | | shares | | earnings | | Total equity | | | £’000 | | £’000 | | £’000 | | £’000 | | £’000 | Balance at 1 July 2023 | | 53 | | 68,822 | | (21,305) | | 246,187 | | 293,757 | Loss for the year | | — | | — | | — | | (51,681) | | (51,681) | Total comprehensive loss for the year | | — | | — | | — | | (51,681) | | (51,681) | Proceeds from issue of shares | | 2 | | 158,539 | | — | | — | | 158,541 | Equity-settled share-based payments | | — | | — | | — | | 876 | | 876 | Balance at 30 June 2024 | | 55 | | 227,361 | | (21,305) | | 195,382 | | 401,493 | Loss for the year | | — | | — | | — | | (899) | | (899) | Total comprehensive loss for the year | | — | | — | | — | | (899) | | (899) | Proceeds from issue of shares | | 1 | | 79,984 | | — | | — | | 79,985 | Equity-settled share-based payments | | — | | — | | — | | 658 | | 658 | Balance at 30 June 2025 | | 56 | | 307,345 | | (21,305) | | 195,141 | | 481,237 | Profit for the year | | — | | — | | — | | 848 | | 848 | Total comprehensive profit for the year | | — | | — | | — | | 848 | | 848 | Equity-settled share-based payments | | — | | — | | — | | 243 | | 243 | Balance at 30 June 2026 | | 56 | | 307,345 | | (21,305) | | 196,232 | | 482,328 |
|
| Statement of condensed statement of cash flows |
| | | | | | | | | Year ended 30 June | | | 2026 | | 2025 | | 2024 | | | £’000 | | £’000 | | £’000 | Cash flows from operating activities | | | | | | | Profit/(loss) before income tax | | 850 | | (898) | | (51,681) | Adjustments for: | | | | | | | Non-cash employee benefit expense - equity-settled share-based payments | | 243 | | 658 | | 875 | Foreign exchange (gains)/losses on operating activities | | (4) | | 18 | | 1 | Changes in working capital: | | | | | | | Other receivables | | — | | — | | (1) | Amounts owed by subsidiaries | | (6,828) | | (6,111) | | (3,371) | Other payables | | 365 | | (6,433) | | 3,216 | Amounts due to subsidiaries | | 5,379 | | 12,486 | | 25,253 | Net cash inflow/(outflow) from operating activities | | 5 | | (280) | | (25,708) | Cash flows from financing activities | | | | | | | Proceeds from issue of shares | | — | | 79,985 | | 158,541 | Net cash inflow from financing activities | | — | | 79,985 | | 158,541 | Cash flows from investing activities | | | | | | | Loans advanced to subsidiaries | | — | | (79,985) | | (133,175) | Net cash outflow from investing activities | | — | | (79,985) | | (133,175) | Effect of exchange rate changes on cash and cash equivalents | | 4 | | (18) | | (1) | Net increase/(decrease) in cash and cash equivalents | | 9 | | (298) | | (343) | Cash and cash equivalents at beginning of year | | 74 | | 372 | | 715 | Cash and cash equivalents at end of year | | 83 | | 74 | | 372 |
|
| Statement of reconciliation of parent and consolidated financial information |
| | | | | | | | | 2026 | | 2025 | | 2024 | | | £’000 | | £’000 | | £’000 | IFRS profit/(loss) reconciliation: | | | | | | | Parent only – IFRS profit/(loss) for the year | | 848 | | (899) | | (51,681) | Additional loss if subsidiaries had been accounted for on the equity method of accounting as opposed to cost | | (43,802) | | (32,124) | | (61,478) | Consolidated IFRS loss for the year | | (42,954) | | (33,023) | | (113,159) | | | | | | | | IFRS equity reconciliation: | | | | | | | Parent only – IFRS equity | | 482,328 | | 481,237 | | 401,493 | Additional loss if subsidiaries had been accounted for on the equity method of accounting as opposed to cost | | (331,965) | | (287,504) | | (256,603) | Consolidated – IFRS equity | | 150,363 | | 193,733 | | 144,890 |
|